Pogledajte cjelovito savjetovanje za više informacija, uključujući ono što bi Kanađani trebali učiniti i rad Ministarstva zdravlja Kanade na rješavanju problema azido nečistoća pronađenih u određenim lijekovima.
| Proizvod | O nama | DIN | Mnogo | istek |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389657 | 2005006959 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389657 | 2005006960 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389657 | 2005006961 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389657 | 2005006962 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389657 | 2005006963 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389657 | 2005011154 | lipnja 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389657 | 2005011156 | lipnja 2023 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389665 | 2005006807 | 2022. XNUMX. |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389665 | 2005006808 | 2022. XNUMX. |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389665 | 2005006809 | 2022. XNUMX. |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389665 | 2005006810 | 2022. XNUMX. |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TAB | Mint Pharmaceuticals Inc. | 02389665 | 2105002149 | prosinca 2022 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 1805012687 | listopada 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 1805012688 | listopada 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 1805012689 | listopada 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 1805012792 | listopada 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 1905001010 | prosinca 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 1905001011 | prosinca 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 2005006947 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 2005006949 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 2005006950 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 2005006951 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 2005007297 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 2005007298 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 2005013776 | 2023. XNUMX. |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TAB | Mint Pharmaceuticals Inc. | 02389673 | 2105002150 | prosinca 2023 |
ŠTO ISKLJUČITI IZ OVOG ČLANKA:
- 023896732005006947April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006949April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006950April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
